Science, politics and the pharmaceutical industry: controversy and bias in drug regulation
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
St. Martin's Press
1995
|
| Ausgabe: | 1. ed. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XI, 308 S. |
| ISBN: | 0312128738 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010908627 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 960822s1995 |||| 00||| eng d | ||
| 020 | |a 0312128738 |9 0-312-12873-8 | ||
| 035 | |a (OCoLC)32468449 | ||
| 035 | |a (DE-599)BVBBV010908627 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a RM301.27 | |
| 082 | 0 | |a 615/.19 |2 20 | |
| 100 | 1 | |a Abraham, John |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Science, politics and the pharmaceutical industry |b controversy and bias in drug regulation |c John Abraham |
| 250 | |a 1. ed. | ||
| 264 | 1 | |a New York |b St. Martin's Press |c 1995 | |
| 300 | |a XI, 308 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Clinical Trials |z Great Britain |v Case Reports | |
| 650 | 4 | |a Clinical Trials |z United States |v Case Reports | |
| 650 | 4 | |a Drug Approval |z Great Britain | |
| 650 | 4 | |a Drug Approval |z United States | |
| 650 | 4 | |a Drug Industry |z Great Britain | |
| 650 | 4 | |a Drug Industry |z United States | |
| 650 | 4 | |a Drug and Narcotic Control |z Great Britain | |
| 650 | 4 | |a Drug and Narcotic Control |z United States | |
| 650 | 4 | |a Drugs |x Testing |x Government policy |z Great Britain | |
| 650 | 4 | |a Drugs |x Testing |x Government policy |z United States | |
| 650 | 4 | |a Drugs |x Toxicology |v Case studies | |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Großbritannien | |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 651 | 7 | |a Großbritannien |0 (DE-588)4022153-2 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4522595-3 |a Fallstudiensammlung |2 gnd-content | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 0 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
| 689 | 1 | 1 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 1 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 2 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 2 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
| 689 | 3 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 3 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 3 | |5 DE-604 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007296822 | ||
Datensatz im Suchindex
| _version_ | 1804125400452825088 |
|---|---|
| adam_text | Contents
Abbreviations v
Preface vii
1 Bias in science and regulation
2 Partial progress? The development of
American and British drug regulation 36
3 Naprosyn — reconstructing data 87
4 Opren/Orajkx the making of a drug disaster 98
5 Feldme the closure of technical dispute 179
6 Zjrniax the persistence of data 206
7 Suprol anything goes? 231
8 Conclusions and policy implications 241
Notes 259
Index 303
iii
|
| any_adam_object | 1 |
| author | Abraham, John |
| author_facet | Abraham, John |
| author_role | aut |
| author_sort | Abraham, John |
| author_variant | j a ja |
| building | Verbundindex |
| bvnumber | BV010908627 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.27 |
| callnumber-search | RM301.27 |
| callnumber-sort | RM 3301.27 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)32468449 (DE-599)BVBBV010908627 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02907nam a2200745 c 4500</leader><controlfield tag="001">BV010908627</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960822s1995 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0312128738</subfield><subfield code="9">0-312-12873-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)32468449</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010908627</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.27</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Abraham, John</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Science, politics and the pharmaceutical industry</subfield><subfield code="b">controversy and bias in drug regulation</subfield><subfield code="c">John Abraham</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">St. Martin's Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 308 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials</subfield><subfield code="z">Great Britain</subfield><subfield code="v">Case Reports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials</subfield><subfield code="z">United States</subfield><subfield code="v">Case Reports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug and Narcotic Control</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug and Narcotic Control</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Government policy</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Toxicology</subfield><subfield code="v">Case studies</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Großbritannien</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4522595-3</subfield><subfield code="a">Fallstudiensammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007296822</subfield></datafield></record></collection> |
| genre | (DE-588)4522595-3 Fallstudiensammlung gnd-content |
| genre_facet | Fallstudiensammlung |
| geographic | Großbritannien USA USA (DE-588)4078704-7 gnd Großbritannien (DE-588)4022153-2 gnd |
| geographic_facet | Großbritannien USA |
| id | DE-604.BV010908627 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:00:57Z |
| institution | BVB |
| isbn | 0312128738 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007296822 |
| oclc_num | 32468449 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XI, 308 S. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | St. Martin's Press |
| record_format | marc |
| spelling | Abraham, John Verfasser aut Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham 1. ed. New York St. Martin's Press 1995 XI, 308 S. txt rdacontent n rdamedia nc rdacarrier Politik Clinical Trials Great Britain Case Reports Clinical Trials United States Case Reports Drug Approval Great Britain Drug Approval United States Drug Industry Great Britain Drug Industry United States Drug and Narcotic Control Great Britain Drug and Narcotic Control United States Drugs Testing Government policy Great Britain Drugs Testing Government policy United States Drugs Toxicology Case studies Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf Großbritannien USA USA (DE-588)4078704-7 gnd rswk-swf Großbritannien (DE-588)4022153-2 gnd rswk-swf (DE-588)4522595-3 Fallstudiensammlung gnd-content USA (DE-588)4078704-7 g Arzneimittelsicherheit (DE-588)4143182-0 s Gesundheitspolitik (DE-588)4113743-7 s DE-604 Großbritannien (DE-588)4022153-2 g Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Abraham, John Science, politics and the pharmaceutical industry controversy and bias in drug regulation Politik Clinical Trials Great Britain Case Reports Clinical Trials United States Case Reports Drug Approval Great Britain Drug Approval United States Drug Industry Great Britain Drug Industry United States Drug and Narcotic Control Great Britain Drug and Narcotic Control United States Drugs Testing Government policy Great Britain Drugs Testing Government policy United States Drugs Toxicology Case studies Arzneimittel (DE-588)4003115-9 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4143182-0 (DE-588)4113743-7 (DE-588)4127410-6 (DE-588)4078704-7 (DE-588)4022153-2 (DE-588)4522595-3 |
| title | Science, politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_auth | Science, politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_exact_search | Science, politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_full | Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham |
| title_fullStr | Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham |
| title_full_unstemmed | Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham |
| title_short | Science, politics and the pharmaceutical industry |
| title_sort | science politics and the pharmaceutical industry controversy and bias in drug regulation |
| title_sub | controversy and bias in drug regulation |
| topic | Politik Clinical Trials Great Britain Case Reports Clinical Trials United States Case Reports Drug Approval Great Britain Drug Approval United States Drug Industry Great Britain Drug Industry United States Drug and Narcotic Control Great Britain Drug and Narcotic Control United States Drugs Testing Government policy Great Britain Drugs Testing Government policy United States Drugs Toxicology Case studies Arzneimittel (DE-588)4003115-9 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd |
| topic_facet | Politik Clinical Trials Great Britain Case Reports Clinical Trials United States Case Reports Drug Approval Great Britain Drug Approval United States Drug Industry Great Britain Drug Industry United States Drug and Narcotic Control Great Britain Drug and Narcotic Control United States Drugs Testing Government policy Great Britain Drugs Testing Government policy United States Drugs Toxicology Case studies Arzneimittel Arzneimittelsicherheit Gesundheitspolitik Zulassung Großbritannien USA Fallstudiensammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT abrahamjohn sciencepoliticsandthepharmaceuticalindustrycontroversyandbiasindrugregulation |